References
2. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among persons aged Q65 years--United States, 1999. MMWR Morb Mortal Wkly Rep 2001;50:532-537.
3. Marin MG, Johanson WG, Salas-Lopez D. Influenza vaccination among minority populations in the United States. Prev Med 2002;34:235-241.
4. Williams WW, Hickson MA, Kane MA, et al. Immunization policies and vaccine coverage among adults. The risk for missed opportunities. Ann Intern Med 1988;108:616-625.
5. Merkel PA, Caputo GC. Evaluation of a simple office-based strategy for increasing influenza vaccine administration and the effect of differing reimbursement plans on the patient acceptance rate. J Gen Intern Med 1994;9:679-683.
6. Zimmerman RK, Silverman M, Janosky JE, et al. A comprehensive investigation of barriers to adult immunization: a methods paper. J Fam Pract 2001;50:703.
7. Hinman AR, Orenstein WA. Adult immunization: what can we learn from the childhood immunization program? Clin Infect Dis 2007;44:1532-1535.
8. Elkin Z, Cohen EJ, Goldberg JD, et al. Studying physician knowledge, attitudes, and practices regarding the herpes zoster vaccine to address perceived barriers to vaccination. Cornea 2013;32:976-981.
9. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Hamborsky J, Kroger A, Wolfe S, eds. Washington, DC: Public Health Foundation; 2015:9-31.
10. Centers for Disease Control and Prevention. Pertussis--United States, 1997-2000. MMWR Morb Mortal Wkly Rep 2002;51:73-76.
11. Skoff TH, Kenyon C, Cocoros N, et al. Sources of infant pertussis infection in the United States. Pediatrics 2015;136:635-641.
12. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Hamborsky J, Kroger A, Wolfe S, eds. Washington, DC: Public Health Foundation; 2015:261-278.
13. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Hamborsky J, Kroger A, Wolfe S, eds. Washington, DC: Public Health Foundation; 2015:187-207.
14. Kim DK, Bridges CB, Harriman KH, et al. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older--United States, 2015. MMWR Morb Mortal Wkly Rep 2015;64:91-92.
15. Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2012;61:816-819.
16. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Hamborsky J, Kroger A, Wolfe S, eds. Washington, DC: Public Health Foundation; 2015:231-243.
17. Bauer T, Jilg W. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 2006;24:572-577.
18. Centers for Disease Control and Prevention. CDC Health Information for Internal Travel. New York: Oxford University Press; 2012.
19. Gergen PJ, McQuillan GM, Kiely M, et al. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995;332:761-766.
20. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Hamborsky J, Kroger A, Wolfe S, eds. Washington, DC: Public Health Foundation; 2015:341-352.
21. McLean HQ, Fiebelkorn AP, Temte JL, et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2013;62(RR-04):1-34.
22. Aberg JA, Gallant JE, Ghanem KG, et al. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2014;58:e1-e34.
23. Kroger AT, Sumaya CV, Pickering LK, et al. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60(RR-02):1-60.
24. Advisory Committee on Immunization Practices, Fiore AE, Wasley A, et al. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55(RR-7):1-23.